Brazilian generics market change after Farmácia Popular program
ABSTRACT OBJECTIVE To evaluate trends in the use of generic and non-generic medicines to treat hypertension and diabetes under the Farmácia Popular Program (FP) and its impact on generic medicines sales volume and market share in the Brazilian pharmaceutical market. METHODS This longitudinal, retr...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Universidade de São Paulo
2019-10-01
|
| Series: | Revista de Saúde Pública |
| Subjects: | |
| Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89102019000100281&tlng=en |
| _version_ | 1828133898604773376 |
|---|---|
| author | Andréa Dâmaso Bertoldi Luisa Arueira Chaves Dennis Ross-Degnan Vera Lucia Luiza Isabel Cristina Martins Emmerick Rondineli Mendes da Silva Mônica Rodrigues Campos |
| author_facet | Andréa Dâmaso Bertoldi Luisa Arueira Chaves Dennis Ross-Degnan Vera Lucia Luiza Isabel Cristina Martins Emmerick Rondineli Mendes da Silva Mônica Rodrigues Campos |
| author_sort | Andréa Dâmaso Bertoldi |
| collection | DOAJ |
| description | ABSTRACT OBJECTIVE To evaluate trends in the use of generic and non-generic medicines to treat hypertension and diabetes under the Farmácia Popular Program (FP) and its impact on generic medicines sales volume and market share in the Brazilian pharmaceutical market. METHODS This longitudinal, retrospective study used interrupted time series design to analyze changes in monthly sales volume and proportion of medicines sales (market share) for oral antidiabetic and antihypertensive medicines for generic versus non-generic products. Analyses were conducted in a combined dataset that aggregate monthly sales volumes from the Farmácia Popular program and from the QuintilesIMS™ (IQVIA) national market sales data from January 2007 to December 2012. The Farmácia Popular program phases analyzed included: a) 2009 reductions in medicines reference prices (AFP-II) and b) 2011 implementation of free medicines program for hypertension and diabetes, the Saúde não tem preço (SNTP – Health has no price). RESULTS Patterns of use for FP-covered antidiabetic and antihypertensive medicines were similar to their use in the market in general. After one year of the decreases in government subsidies in April 2010, market share of antidiabetic and antihypertensive medicines experienced relative declines of -54.5% and -59.9%, respectively. However, when FP-covered medicines were made free to patients, overall market volume for antidiabetic and antihypertensive generics increased dramatically, with 242.6% and 277.0% relative increases by February 2012, as well as non-generics with relative increase of 209.7% and 279% for antidiabetic and antihypertensive medicines, respectively. CONCLUSIONS Ministry of Health policies on the amount of patient cost sharing and on the choice of medicines on coverage lists have substantial impacts on overall generic sales volume in retail pharmacies. |
| first_indexed | 2024-04-11T17:26:17Z |
| format | Article |
| id | doaj.art-f4d5dfd769c44294b5030e55d1d261f1 |
| institution | Directory Open Access Journal |
| issn | 1518-8787 |
| language | English |
| last_indexed | 2024-04-11T17:26:17Z |
| publishDate | 2019-10-01 |
| publisher | Universidade de São Paulo |
| record_format | Article |
| series | Revista de Saúde Pública |
| spelling | doaj.art-f4d5dfd769c44294b5030e55d1d261f12022-12-22T04:12:20ZengUniversidade de São PauloRevista de Saúde Pública1518-87872019-10-015310.11606/s1518-8787.2019053001237Brazilian generics market change after Farmácia Popular programAndréa Dâmaso Bertoldihttps://orcid.org/0000-0002-4680-3197Luisa Arueira Chaveshttps://orcid.org/0000-0002-9597-3651Dennis Ross-Degnanhttps://orcid.org/0000-0002-0066-1242Vera Lucia Luizahttps://orcid.org/0000-0001-6245-7522Isabel Cristina Martins Emmerickhttps://orcid.org/0000-0002-0383-2465Rondineli Mendes da Silvahttps://orcid.org/0000-0002-6243-5179Mônica Rodrigues Camposhttps://orcid.org/0000-0002-7443-5977ABSTRACT OBJECTIVE To evaluate trends in the use of generic and non-generic medicines to treat hypertension and diabetes under the Farmácia Popular Program (FP) and its impact on generic medicines sales volume and market share in the Brazilian pharmaceutical market. METHODS This longitudinal, retrospective study used interrupted time series design to analyze changes in monthly sales volume and proportion of medicines sales (market share) for oral antidiabetic and antihypertensive medicines for generic versus non-generic products. Analyses were conducted in a combined dataset that aggregate monthly sales volumes from the Farmácia Popular program and from the QuintilesIMS™ (IQVIA) national market sales data from January 2007 to December 2012. The Farmácia Popular program phases analyzed included: a) 2009 reductions in medicines reference prices (AFP-II) and b) 2011 implementation of free medicines program for hypertension and diabetes, the Saúde não tem preço (SNTP – Health has no price). RESULTS Patterns of use for FP-covered antidiabetic and antihypertensive medicines were similar to their use in the market in general. After one year of the decreases in government subsidies in April 2010, market share of antidiabetic and antihypertensive medicines experienced relative declines of -54.5% and -59.9%, respectively. However, when FP-covered medicines were made free to patients, overall market volume for antidiabetic and antihypertensive generics increased dramatically, with 242.6% and 277.0% relative increases by February 2012, as well as non-generics with relative increase of 209.7% and 279% for antidiabetic and antihypertensive medicines, respectively. CONCLUSIONS Ministry of Health policies on the amount of patient cost sharing and on the choice of medicines on coverage lists have substantial impacts on overall generic sales volume in retail pharmacies.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89102019000100281&tlng=enDrugs, Generic, economicsGeneric Drug PolicyAntihypertensive Agents, supply & distributionHypoglycemic Agents, supply & distribution |
| spellingShingle | Andréa Dâmaso Bertoldi Luisa Arueira Chaves Dennis Ross-Degnan Vera Lucia Luiza Isabel Cristina Martins Emmerick Rondineli Mendes da Silva Mônica Rodrigues Campos Brazilian generics market change after Farmácia Popular program Revista de Saúde Pública Drugs, Generic, economics Generic Drug Policy Antihypertensive Agents, supply & distribution Hypoglycemic Agents, supply & distribution |
| title | Brazilian generics market change after Farmácia Popular program |
| title_full | Brazilian generics market change after Farmácia Popular program |
| title_fullStr | Brazilian generics market change after Farmácia Popular program |
| title_full_unstemmed | Brazilian generics market change after Farmácia Popular program |
| title_short | Brazilian generics market change after Farmácia Popular program |
| title_sort | brazilian generics market change after farmacia popular program |
| topic | Drugs, Generic, economics Generic Drug Policy Antihypertensive Agents, supply & distribution Hypoglycemic Agents, supply & distribution |
| url | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89102019000100281&tlng=en |
| work_keys_str_mv | AT andreadamasobertoldi braziliangenericsmarketchangeafterfarmaciapopularprogram AT luisaarueirachaves braziliangenericsmarketchangeafterfarmaciapopularprogram AT dennisrossdegnan braziliangenericsmarketchangeafterfarmaciapopularprogram AT veralucialuiza braziliangenericsmarketchangeafterfarmaciapopularprogram AT isabelcristinamartinsemmerick braziliangenericsmarketchangeafterfarmaciapopularprogram AT rondinelimendesdasilva braziliangenericsmarketchangeafterfarmaciapopularprogram AT monicarodriguescampos braziliangenericsmarketchangeafterfarmaciapopularprogram |